[Treatment of rheumatoid arthritis with a preparation of Sanokrizin--intravenous administration].
Treatment with the preparation "Sanokrizin", applied i. v. has been carried out to 50 patients with rheumatoid polyarthritis--32 seropositive and 18 seronegative forms, being with a duration of the morbid process from one to 17 years. Therapeutic effect was obtained in 78 per cent of the cases, followed up from six months to one year while that therapy proved to be without effect in 22 per cent of the patients or only separate symptoms of the inflammatory process were partially affected. The preparation has a good tolerance and the side-effects, in the absence of controlled auremia, are overcome with discontinuation of the carried out treatment and only to two of the patients corticosteroids were given additionally. With an average dose, per course, of 1751,60 mg effect was also obtained upon single symptoms of the rheumatoid inflammation. The patients, effected at the earliest in the course of the therapeutic process, are with the best and most durable therapeutic effect and that might be used as a prognostic criterion for the favourable effect of the carried out treatment with the preparation "Sanokrizin".